119 related articles for article (PubMed ID: 7704565)
1. The pathogenesis of chronic obstructive lung diseases: implications for therapy.
Stockley RA
QJM; 1995 Feb; 88(2):141-6. PubMed ID: 7704565
[No Abstract] [Full Text] [Related]
2. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy].
Rasche B; Hochstrasser K
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():725-7. PubMed ID: 6557570
[No Abstract] [Full Text] [Related]
3. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
Kramps JA; Dijkman JH
Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1127-30. PubMed ID: 2192289
[No Abstract] [Full Text] [Related]
4. [Proteases and protease inhibitors; etiologic role in chronic obstructive emphysema].
Kueppers F
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():700-2. PubMed ID: 6359127
[No Abstract] [Full Text] [Related]
5. Selection of a therapeutic agent for the treatment of chronic obstructive pulmonary disease in smokers.
Turino GM; Davies P; Dunlap R; Krell RD; Maycock AL; Rennard S; Stockley RA
Ann N Y Acad Sci; 1991 Dec; 624 Suppl():23-30. PubMed ID: 1686162
[No Abstract] [Full Text] [Related]
6. Letter: Familial variation of leukocyte lysosomal protease and serum alpha 1-antitrypsin as determinants in chronic obstructive pulmonary diseases.
Leiberman J
Am Rev Respir Dis; 1973 Oct; 108(4):1019-20. PubMed ID: 4542640
[No Abstract] [Full Text] [Related]
7. [Changes of neutrophil elastase in COPD and the role of elastase in experimental pulmonary hypertension].
Yan YZ
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Dec; 11(6):324-6, 384. PubMed ID: 3250749
[No Abstract] [Full Text] [Related]
8. Letter: Familial variation of leukocyte lysosomal protease and serum alpha 1-antitrypsin as determinants in chronic obstructive pulmonary disease.
Galdston M; Davis AL; Janoff A
Am Rev Respir Dis; 1973 Oct; 108(4):1020-1. PubMed ID: 4542641
[No Abstract] [Full Text] [Related]
9. [Experimental observation on protease-antiprotease balance in rats exposed to hyperoxia].
Mao J
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Oct; 9(5):293-5, 319. PubMed ID: 3643092
[No Abstract] [Full Text] [Related]
10. Proteases and antiproteases in the lung.
Am Rev Respir Dis; 1983 Feb; 127(2):S1-58. PubMed ID: 6338778
[No Abstract] [Full Text] [Related]
11. [Anti-elastolytic inhibitory capacity and IgA deficiency--contribution to the etiopathogenesis of COPD].
Schultek T; Braun J; Wood WG; Wiessmann KJ
Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():307-8. PubMed ID: 3174583
[No Abstract] [Full Text] [Related]
12. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction.
Rasche B
Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later.
Shapiro SD
Proc Assoc Am Physicians; 1995 Oct; 107(3):346-52. PubMed ID: 8608421
[TBL] [Abstract][Full Text] [Related]
14. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
Groutas WC; Chong LS; Venkataraman R
Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
[TBL] [Abstract][Full Text] [Related]
15. [Lung tissue changes in irreversible airflow obstruction--emphysema and small airway disease].
Sutinen S
Duodecim; 1993; 109(12):1061-9. PubMed ID: 8062677
[No Abstract] [Full Text] [Related]
16. Role of connective tissue proteases in the pathogenesis of chronic inflammatory lung disease.
Gadek JE; Fells GA; Zimmerman RL; Crystal RG
Environ Health Perspect; 1984 Apr; 55():297-306. PubMed ID: 6329673
[TBL] [Abstract][Full Text] [Related]
17. [Protease inhibitors and chronic respiratory diseases].
Endres P
Prax Klin Pneumol; 1981 Jun; 35(6):249-62. PubMed ID: 6973150
[No Abstract] [Full Text] [Related]
18. Familial variation of leukocyte lysosomal protease and serum 1 -antitrypsin as determinants in chronic obstructive pulmonary disease.
Galdston M; Janoff A; Davis AL
Am Rev Respir Dis; 1973 May; 107(5):718-27. PubMed ID: 4695623
[No Abstract] [Full Text] [Related]
19. Substituted 2-pyrones, 2-pyridones, and other congeners of elasnin as potential agents for the treatment of chronic obstructive lung diseases.
Groutas WC; Stanga MA; Brubaker MJ; Huang TL; Moi MK; Carroll RT
J Med Chem; 1985 Aug; 28(8):1106-9. PubMed ID: 3848491
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary injury by proteases of exogenous and endogenous origin].
Trojani FT
Clin Ter; 1994 Aug; 145(8):171-3. PubMed ID: 7955965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
